Sino Biopharmaceutical Limited
SBMFF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19,823,304 | $19,823,304 | $9,569,584 | $9,569,584 |
| Short-Term Investments | $0 | $0 | $5,027,688 | $5,027,688 |
| Receivables | $8,286,593 | $8,286,593 | $5,012,638 | $4,967,560 |
| Inventory | $2,103,865 | $2,103,865 | $2,373,145 | $2,373,145 |
| Other Curr. Assets | $159,350 | $159,350 | $250,532 | $295,610 |
| Total Curr. Assets | $33,820,318 | $33,820,318 | $24,685,331 | $24,685,331 |
| Property Plant & Equip (Net) | $10,053,815 | $10,053,815 | $10,288,156 | $10,288,156 |
| Goodwill | $911,711 | $911,711 | $915,689 | $915,689 |
| Intangibles | $2,207,744 | $2,207,744 | $2,145,277 | $2,145,277 |
| Long-Term Investments | $26,927,328 | $26,927,328 | $26,336,532 | $26,336,532 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $973,490 | $973,490 | $1,037,084 | $1,037,084 |
| Total NC Assets | $41,074,088 | $41,074,088 | $40,722,738 | $40,722,738 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $74,894,406 | $74,894,406 | $65,408,069 | $65,408,069 |
| Liabilities | – | – | – | – |
| Payables | $2,820,277 | $2,820,277 | $1,497,461 | $1,497,461 |
| Short-Term Debt | $8,852,190 | $8,852,190 | $7,675,363 | $7,675,363 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13,157,882 | $13,157,882 | $7,610,311 | $10,355,333 |
| Total Curr. Liab. | $24,850,610 | $24,850,610 | $19,556,490 | $19,556,490 |
| LT Debt | $2,999,442 | $2,999,442 | $1,996,752 | $1,996,752 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,182,621 | $1,182,621 | $997,364 | $997,364 |
| Total NC Liab. | $4,266,081 | $4,266,081 | $3,077,509 | $3,077,509 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $104,279 | $104,279 | $111,726 | $111,726 |
| Total Liabilities | $29,116,691 | $29,116,691 | $22,633,999 | $22,633,999 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $413,680 | $413,680 | $414,384 | $414,384 |
| Retained Earnings | $28,018,847 | $28,018,847 | $25,280,560 | $25,280,560 |
| AOCI | -$4,395,698 | -$4,395,698 | $0 | -$3,179,990 |
| Other Equity | $0 | $0 | -$3,157,299 | $0 |
| Total Equity | $33,373,574 | $33,373,574 | $31,960,789 | $31,960,789 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $12,404,141 | $12,404,141 | $10,813,281 | $10,813,281 |
| Total Liab. & Tot. Equity | $74,894,406 | $74,894,406 | $65,408,069 | $65,408,069 |
| Net Debt | -$7,971,672 | -$7,971,672 | $102,531 | $102,531 |